Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001956827-26-000012
Filing Date
2026-03-23
Accepted
2026-03-23 16:54:47
Documents
165
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 20-F abvx-20251231.htm   iXBRL 20-F 9341463
2 EX-1.1 abivax-20xfxex11bylaws6feb.htm EX-1.1 153350
3 EX-2.1 abivax-20xfxex21descriptio.htm EX-2.1 227401
4 EX-4.16 abivax-20xfxex416summaryof.htm EX-4.16 18936
5 EX-4.17 abivax-20xfxex417summaryof.htm EX-4.17 8851
6 EX-4.18 abivax-20xfxex418summaryof.htm EX-4.18 47646
7 EX-11.1 a03abivax-ipoxboardbookxco.htm EX-11.1 137971
8 EX-12.1 abivax-202520xfxex121ceo.htm EX-12.1 10721
9 EX-12.2 abivax-202520xfxex122cfo.htm EX-12.2 9614
10 EX-13.1 abivax-202520xfxex131ceo.htm EX-13.1 4395
11 EX-13.2 abivax-202520xfxex132cfo.htm EX-13.2 4460
12 EX-15.1 pwc_consentx20-fxfy25.htm EX-15.1 1809
18 abvx-20251231_g1.gif GRAPHIC 201048
19 abvx-20251231_g10.gif GRAPHIC 98146
20 abvx-20251231_g11.gif GRAPHIC 101284
21 abvx-20251231_g12.gif GRAPHIC 55609
22 abvx-20251231_g13.jpg GRAPHIC 20930
23 abvx-20251231_g2.gif GRAPHIC 62598
24 abvx-20251231_g3.gif GRAPHIC 129266
25 abvx-20251231_g4.gif GRAPHIC 49801
26 abvx-20251231_g5.gif GRAPHIC 84928
27 abvx-20251231_g6.gif GRAPHIC 66150
28 abvx-20251231_g7.gif GRAPHIC 75932
29 abvx-20251231_g8.gif GRAPHIC 51884
30 abvx-20251231_g9.gif GRAPHIC 54279
  Complete submission text file 0001956827-26-000012.txt   38024999

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abvx-20251231.xsd EX-101.SCH 189221
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abvx-20251231_cal.xml EX-101.CAL 126046
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abvx-20251231_def.xml EX-101.DEF 915898
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abvx-20251231_lab.xml EX-101.LAB 1306227
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abvx-20251231_pre.xml EX-101.PRE 1182582
169 EXTRACTED XBRL INSTANCE DOCUMENT abvx-20251231_htm.xml XML 7943019
Mailing Address 7 BD HAUSSMANN PARIS France
Business Address 7 BD HAUSSMANN PARIS France 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41842 | Film No.: 26783055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)